Sun Pharma Advanced Research Company Limited has informed the Exchange regarding a press release dated December 08, 2021, titled "SPARC Licenses Development and Commercialization Rights of PDP-716 and SDN-037 to Visiox Pharma.".
Press Release Dec 08 2021
Filed with NSE ·
6ix hasn’t read this filing yet.
Sun Pharma Advanced Research Co. Ltd. on 6ix
In the deck
Earlier from Sun Pharma Advanced Research
- SPARC Licenses Development and Commercialization Rights of PDP-716 and SDN-037 to Visiox Pharma
- Press Release Dec 03 2021
- Press Release Nov 26 2021
- AGM Speech 2020-21
- Press Release May 14 2021
Later from Sun Pharma Advanced Research
- Update on SPARC strategy and portfolio
- Press Release Dec 10 2021
- Press Release (Revised) Dec 10 2021
- Corporate Presentation
- FY 2021-22
Follow Sun Pharma Advanced Research into a list and get an email when it puts out news.
Follow Sun Pharma Advanced Research